Drugs / Metformin Oral Tablet
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04120259 | Apr → Aug 2019 | type 2 diabetes mellitus | Ziauddin University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metformin Oral Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04120259 ↗ |
| Modality | Small molecule | “A biguanide drug used as a first line therapy for Diabetes MellitusType 2” NCT04120259 ↗ |
| Route | Oral | “Intervention: Metformin Tablet oral 750 mg OD” NCT04120259 ↗ |